Literature DB >> 7957447

Kidney and liver contributions to salicylate metabolism in rats.

M Láznícek1, A Láznícková.   

Abstract

The pharmacokinetics and metabolism of radiolabelled salicylate were studied in rats and compared with that of the isolated perfused rat liver and the perfused rat kidney. Both parent compound and salicylate metabolites (mainly conjugates with glycine and glucuronic acid) were eliminated mostly into urine. The comparison of a relative proportion of metabolites eliminated in whole rats with that of the isolated perfused rat liver and the perfused rat kidney showed that both kidney and liver contributed to the salicylate metabolism. The glycine conjugate of salicylate was formed predominantly in the kidney whereas both kidney and liver participated in the formation of glucuronic acid derivatives.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957447     DOI: 10.1007/BF03188818

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  11 in total

Review 1.  Pharmacokinetics of salicylate in man.

Authors:  G Levy
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

2.  Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics.

Authors:  T Tsuchiya; G Levy
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

3.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

4.  Renal contribution to overall metabolism of drugs. II. Biotransformation of salicylic acid to salicyluric acid.

Authors:  S H Wan; S Riegelman
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

5.  Pharmacokinetics of salicylate elimination in man.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

6.  [The role of the kidney and liver in the total metabolism of (125I) ortho-iodobenzoate in rats].

Authors:  M Láznícek; A Láznícková; J Kvĕtina
Journal:  Cesk Farm       Date:  1990-10

7.  99mTc complexes of ethylenediaminetetraacetic and ethylenediaminetetraacetohydroxamic acids; labelling and biodistribution.

Authors:  A Láznícková; R Karlícek; J Kvĕtina; L Kronrád; V Kusák
Journal:  Int J Nucl Med Biol       Date:  1984

8.  Tissue distribution of drug-metabolizing enzymes in humans.

Authors:  G M Pacifici; M Franchi; C Bencini; F Repetti; N Di Lascio; G B Muraro
Journal:  Xenobiotica       Date:  1988-07       Impact factor: 1.908

9.  Metabolism of salicylic acid in the isolated perfused rat kidney. Interconversion of salicyluric and salicyclic acids.

Authors:  I Bekersky; W A Colburn; L Fishman; S A Kaplan
Journal:  Drug Metab Dispos       Date:  1980 Sep-Oct       Impact factor: 3.922

10.  Protein binding of tolfenamic acid in the plasma from patients with renal and hepatic disease.

Authors:  M Láznícek; K E Senius
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.